Aurobindo Pharma arm launches Adquey in US

Acrotech Biopharma, a subsidiary of Aurobindo Pharma, has launched Adquey in the U.S. for the treatment of mild-to-moderate atopic dermatitis and established a dedicated dermatology business unit. The launch marks Acrotech's entry into the US dermatology market and expands the company's commercial presence.